Latest Derivatives News

Change Financial Limited reported a robust Q2 FY25 with revenue surging 53% year-on-year, driven by its expanding PaaS platform, while strategically exiting its loss-making US operations to sharpen focus on Australia and New Zealand.

Torque Metals and Aston Minerals have updated shareholders on their merger, confirming the share exchange ratio and appointing an independent expert to assess the deal's fairness.

Entyr Limited has ramped up tyre receivals and processing volumes in the December quarter, alongside securing new supply and offtake agreements as it prepares for ASX reinstatement. The company’s ongoing plant upgrades and strategic partnerships signal a potential turnaround in its operational and financial trajectory.

Tissue Repair Limited has commenced patient randomisation in its Phase 3 trial of TR987®, targeting chronic venous leg ulcers, aiming to confirm promising earlier results and potentially transform wound healing treatment.

Neurotech International reports key clinical progress in paediatric neurological disorders, securing FDA orphan drug designation for its Rett Syndrome treatment and advancing pivotal trials for ASD and PANDAS/PANS.

Bio-Gene Technology Limited has been awarded two U.S. Department of Defense grants totaling A$3 million to develop innovative insect control products targeting military and civilian markets.

Algorae Pharmaceuticals reports robust progress in its drug development pipeline, highlighted by promising preclinical results for cardiovascular and dementia candidates and significant AI platform enhancements.

Greenvale Energy has significantly expanded its uranium portfolio with key acquisitions in the Northern Territory and Queensland, supported by promising airborne survey results and progress in its Alpha Torbanite Project.

Burley Minerals has reported robust iron assay results from its Cane Bore Iron Project, significantly enlarging prospective drilling areas and advancing towards a maiden drilling program pending heritage and regulatory approvals.

Noxopharm’s December 2024 quarterly report reveals expanding global interest in its Sofra technology through new Material Transfer Agreements and a strengthened cash position following a significant R&D tax rebate.

Hamelin Gold's latest soil sampling at the Anderson project in WA reveals strong gold anomalism, identifying new bedrock sources and expanding the project area to 500km². Further sampling aims to refine drill targets in this promising Wheatbelt region.

Metals Australia Ltd reported robust progress in its December 2024 quarter, including a drilling permit award and a threefold land increase at its Lac Carheil Graphite Project, alongside advancing prefeasibility and metallurgical studies. Exploration success at Corvette River and Warrego East further underscores the company’s diversified critical minerals and gold portfolio.